Boehringer Ingelheim Press Releases

Press Release Subscription: Signup here to the Boehringer Ingelheim Newsletter to receive press-releases via email.

Information for...

General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US and UK Journalists Jobseekers

PRESS RELEASE 10 Sep 2020 at 14:00

Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers

Read more on Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers
PRESS RELEASE 27 Aug 2020 at 15:00

Boehringer Ingelheim Announces U.S. Country Managing Director Jean-Michel Boers Appointed to PhRMA Board of Directors

Read more on Boehringer Ingelheim Announces U.S. Country Managing Director Jean-Michel Boers Appointed to PhRMA Board of Directors
PRESS RELEASE 18 Aug 2020 at 08:00

Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats

Read more on Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
PRESS RELEASE 17 Aug 2020 at 09:00

Boehringer Ingelheim Supports BioLabs First European Location BioLabs Heidelberg with Founding Sponsorship

Read more on Boehringer Ingelheim Supports BioLabs First European Location BioLabs Heidelberg with Founding Sponsorship
PRESS RELEASE 12 Aug 2020 at 14:00

Phase III InPedILD™ trial enrolls first patient to evaluate nintedanib in pediatric population with fibrosing interstitial lung disease

Read more on Phase III InPedILD™ trial enrolls first patient to evaluate nintedanib in pediatric population with fibrosing interstitial lung disease
PRESS RELEASE 03 Aug 2020 at 08:30

First half 2020: Fight against COVID-19 pandemic shapes global business activities of Boehringer Ingelheim

Read more on First half 2020: Fight against COVID-19 pandemic shapes global business activities of Boehringer Ingelheim
PRESS RELEASE 27 Jul 2020 at 10:00

Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health

Read more on Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health
PRESS RELEASE 15 Jul 2020 at 14:45

European Commission approves third nintedanib indication in pulmonary fibrosis1

Read more on European Commission approves third nintedanib indication in pulmonary fibrosis1
PRESS RELEASE 09 Jul 2020 at 14:30

Fighting antibiotic resistance: Boehringer Ingelheim joins AMR Action Fund

Read more on Fighting antibiotic resistance: Boehringer Ingelheim joins AMR Action Fund
PRESS RELEASE 07 Jul 2020 at 14:00

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

Read more on Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
PRESS RELEASE 02 Jul 2020 at 15:00

Boehringer Ingelheim Launches External Innovation Hub in China

Read more on Boehringer Ingelheim Launches External Innovation Hub in China
PRESS RELEASE 25 Jun 2020 at 08:00

Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved

Read more on Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved
PRESS RELEASE 08 Jun 2020 at 14:00

New consortium EUbOPEN will provide tools to unlock disease biology

Read more on New consortium EUbOPEN will provide tools to unlock disease biology
PRESS RELEASE 04 Jun 2020 at 08:00

“LastMile” – improving through digital

Read more on “LastMile” – improving through digital
PRESS RELEASE 29 May 2020 at 13:00

Boehringer Ingelheim receives positive CHMP opinion for a third nintedanib indication in pulmonary fibrosis1

Read more on Boehringer Ingelheim receives positive CHMP opinion for a third nintedanib indication in pulmonary fibrosis1
PRESS RELEASE 25 May 2020 at 17:00

Winners of 2020 BVDzero Case Awards announced

Read more on Winners of 2020 BVDzero Case Awards announced
PRESS RELEASE 14 May 2020 at 14:00

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio

Read more on Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio
PRESS RELEASE 13 May 2020 at 14:00

Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide

Read more on Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
PRESS RELEASE 21 Apr 2020 at 09:00

European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Read more on European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
PRESS RELEASE 21 Apr 2020 at 08:15

Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey

Read more on Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey